Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 38.72B | 36.42B | 31.92B | 29.46B | 30.47B |
Gross Profit | 8.72B | 8.30B | 6.90B | 6.41B | 6.39B |
EBITDA | 4.01B | 3.55B | 2.33B | 2.12B | 1.99B |
Net Income | 2.68B | 2.53B | 1.55B | 1.16B | 1.37B |
Balance Sheet | |||||
Total Assets | 33.88B | 31.59B | 27.07B | 23.92B | 23.55B |
Cash, Cash Equivalents and Short-Term Investments | 9.61B | 10.27B | 9.89B | 8.87B | 9.81B |
Total Debt | 17.53M | 23.75M | 15.62M | 21.72M | 14.41M |
Total Liabilities | 13.40B | 13.31B | 11.89B | 10.25B | 10.89B |
Stockholders Equity | 20.48B | 18.28B | 15.18B | 13.67B | 12.67B |
Cash Flow | |||||
Free Cash Flow | 2.72B | 1.48B | 2.23B | 236.63M | 1.83B |
Operating Cash Flow | 2.80B | 1.59B | 2.30B | 394.63M | 2.18B |
Investing Cash Flow | -2.45B | -662.86M | -796.60M | -906.11M | -641.55M |
Financing Cash Flow | -1.02B | -545.52M | -478.27M | -429.62M | -464.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥36.07B | 13.53 | 2.85% | 6.32% | 5.89% | ||
61 Neutral | $35.09B | 8.26 | -10.58% | 1.90% | 8.56% | -9.51% | |
― | €217.23M | 39.46 | 3.05% | ― | ― | ― | |
80 Outperform | ¥38.89B | 6.93 | 2.15% | -0.10% | 1.43% | ||
78 Outperform | ¥43.58B | 11.43 | 2.69% | 5.64% | 27.01% | ||
70 Outperform | ¥33.84B | 19.34 | 5.15% | -3.69% | -22.95% | ||
62 Neutral | ¥27.91B | 17.23 | 1.17% | 15.16% | -7.96% |